16-1215315-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_021098.3(CACNA1H):c.5113G>A(p.Ala1705Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00716 in 1,611,068 control chromosomes in the GnomAD database, including 42 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0057 ( 5 hom., cov: 33)
Exomes 𝑓: 0.0073 ( 37 hom. )
Consequence
CACNA1H
NM_021098.3 missense
NM_021098.3 missense
Scores
2
10
7
Clinical Significance
Conservation
PhyloP100: 9.78
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.011093318).
BP6
Variant 16-1215315-G-A is Benign according to our data. Variant chr16-1215315-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 377230.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1215315-G-A is described in Lovd as [Benign]. Variant chr16-1215315-G-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0057 (869/152328) while in subpopulation NFE AF= 0.00858 (584/68026). AF 95% confidence interval is 0.00801. There are 5 homozygotes in gnomad4. There are 374 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 869 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1H | NM_021098.3 | c.5113G>A | p.Ala1705Thr | missense_variant | 29/35 | ENST00000348261.11 | NP_066921.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1H | ENST00000348261.11 | c.5113G>A | p.Ala1705Thr | missense_variant | 29/35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
CACNA1H | ENST00000565831.6 | c.5095G>A | p.Ala1699Thr | missense_variant | 27/33 | 1 | ENSP00000455840.1 | |||
CACNA1H | ENST00000638323.1 | c.5074G>A | p.Ala1692Thr | missense_variant | 29/35 | 5 | ENSP00000492267.1 | |||
CACNA1H | ENST00000569107.5 | c.1351G>A | p.Ala451Thr | missense_variant | 11/17 | 1 | ENSP00000454990.2 | |||
CACNA1H | ENST00000564231.5 | c.1336G>A | p.Ala446Thr | missense_variant | 12/18 | 1 | ENSP00000457555.2 | |||
CACNA1H | ENST00000562079.5 | c.1318G>A | p.Ala440Thr | missense_variant | 11/17 | 1 | ENSP00000454581.2 | |||
CACNA1H | ENST00000639478.1 | n.*194G>A | non_coding_transcript_exon_variant | 29/35 | 5 | ENSP00000491945.1 | ||||
CACNA1H | ENST00000640028.1 | n.*2964G>A | non_coding_transcript_exon_variant | 29/35 | 5 | ENSP00000491488.1 | ||||
CACNA1H | ENST00000639478.1 | n.*194G>A | 3_prime_UTR_variant | 29/35 | 5 | ENSP00000491945.1 | ||||
CACNA1H | ENST00000640028.1 | n.*2964G>A | 3_prime_UTR_variant | 29/35 | 5 | ENSP00000491488.1 |
Frequencies
GnomAD3 genomes AF: 0.00570 AC: 868AN: 152210Hom.: 5 Cov.: 33
GnomAD3 genomes
AF:
AC:
868
AN:
152210
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00556 AC: 1356AN: 243960Hom.: 6 AF XY: 0.00551 AC XY: 731AN XY: 132768
GnomAD3 exomes
AF:
AC:
1356
AN:
243960
Hom.:
AF XY:
AC XY:
731
AN XY:
132768
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00731 AC: 10664AN: 1458740Hom.: 37 Cov.: 33 AF XY: 0.00711 AC XY: 5161AN XY: 725390
GnomAD4 exome
AF:
AC:
10664
AN:
1458740
Hom.:
Cov.:
33
AF XY:
AC XY:
5161
AN XY:
725390
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00570 AC: 869AN: 152328Hom.: 5 Cov.: 33 AF XY: 0.00502 AC XY: 374AN XY: 74486
GnomAD4 genome
AF:
AC:
869
AN:
152328
Hom.:
Cov.:
33
AF XY:
AC XY:
374
AN XY:
74486
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
40
ALSPAC
AF:
AC:
26
ESP6500AA
AF:
AC:
7
ESP6500EA
AF:
AC:
79
ExAC
AF:
AC:
670
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:6
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Nov 22, 2019 | - - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2024 | CACNA1H: BS2 - |
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Sep 15, 2016 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jan 31, 2023 | - - |
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D;.;.;.
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;D;D;.
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Pathogenic
D
MutationAssessor
Benign
L;.;.;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;.;D;D
REVEL
Uncertain
Sift
Benign
T;.;T;T
Sift4G
Uncertain
D;.;D;D
Polyphen
D;.;D;D
Vest4
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at